Lobular carcinoma in situ and atypical lobular hyperplasia were first described over 50 years
ago. Despite this long incubation period, the biological nature of the lesions remains …

Lobular neoplasia and atypical ductal hyperplasia (ADH) are high-risk breast lesions
associated with an increased risk of breast cancer. Until recently, surgical excision was …

AIM: To retrospectively review the surgical histological findings in all cases where lobular
carcinomain situ (LCIS) was identified on percutaneous core biopsy (CB) performed as part …

Context.—Percutaneous image-guided core biopsy is increasingly becoming the method of
choice to evaluate impalpable breast lesions presenting with mammographically detected …

Atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) are nonmalignant breast
lesions that confer a 4-to 10-fold increased risk for breast cancer in women. Often, AH and …

The current histological classification of in‐situ and invasive lobular carcinomas (ILCs)
includes different morphological variants, some of which have been recently described. In …

Lobular carcinoma is a special type of breast cancer that shows distinct clinical presentation,
morphologic and molecular features, and clinical behavior, and its incidence is rising in …

OBJECTIVE. Pleomorphic lobular carcinoma in situ (PLCIS) is an aggressive subtype of
lobular carcinoma in situ treated similarly to ductal carcinoma in situ. The purpose of this …

The diagnosis of lobular carcinoma in situ (LCIS) provokes considerable anxiety in patients
owing to misconceptions about this diagnosis. Initially LCIS was considered a premalignant …

This review reflects a collaboration between the American Registry of Pathology (the
publisher of the Armed Forces Institute of Pathology Fascicles) and Annals of Diagnostic …